Dexcom, Inc. develops and manufactures continuous glucose monitoring (CGM) systems that provide real-time glucose data for individuals managing diabetes. Its primary products include the Dexcom G7 and Stelo Glucose Biosensor, which enable users to track glucose levels and understand how various factors affect their health. The company serves a diverse customer base, including individuals with all types of diabetes, and operates primarily in the healthcare sector across multiple geographies. Dexcom generates revenue through the sale of its CGM devices and related technologies.
No recent RNS announcements for 1DXCM across 1DXCM, DXCM.
No recent RNS announcements for 1DXCM across 1DXCM, DXCM.